Musculoskeletal Diseases or ConditionsNCT07007299
Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident
An observational study of Musculoskeletal Diseases or Conditions and Traffic Accident, run by Jaseng Medical Foundation at 4 sites in South Korea.
Trial summary
The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Musculoskeletal Diseases or Conditions, Traffic Accident, Elderly (People Aged 65 or More)
- How many people
- 1,788 participants
- Where
- 4 sitesSouth Korea
- Study dates
- 16 Jul 2024to 28 Jul 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: From January 1, 2021 to December 31, 2023, only patients aged 65 years or older who visited the four branches of Jaseng Oriental Hospital (Gangnam, Bucheon, Daejeon, Haeundae) and received inpatient treatment after being injured in a traffic accident and who meet the selection criteria are eligible.
Who may be able to join
- Patients aged 65 years or older at the time of first visit
- Patients who visited our hospital due to symptoms caused by a traffic accident and received integrated oriental medicine treatment at least once as an inpatient treatment
Who cannot join
- If only consultation was conducted at the hospital or only Western medicine treatment was conducted
- If only outpatient treatment was received without hospitalization
- If other researcher judges that participation in the study is difficult
Trial locations and contacts
4 sites in 1 country.
South Korea4 sites
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi-do, 14598
Haeundae Jaseng Hospital of Korean Medicine
Busan
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, Daejeon, 35262
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896
About this study
Official title: Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident: Retrospective Chart Review Study
The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.
Read the detailed description
This study was retrospective chart review study and was conducted in 4 branches of Jaseng Korean Medicine Hospital (Gangnam, Bucheon, Daejeon, Haeundae).
- Conditions
- Musculoskeletal Diseases or Conditions, Traffic Accident, Elderly (People Aged 65 or More)
- Keywords
- pharmacopuncture, herbal medicine, elderly, korean medicine, complementary and alternative medicine, acupuncture
- Medical subject headings
- Musculoskeletal Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Numeric Rating Scale (NRS)
NRS uses an 11-point scale to evaluate current main pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.
Measured: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Secondary outcomes (4)
euroqol-5 dimension (EQ-5D)
EQ-5D is most widely used as a method of indirectly calculating the quality of life from various aspects. The EQ-5D consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about).
Measured: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Neck Disability Index (NDI)
NDI is a functional disability questionnaire. The possible range of each item score is 0 to 5. Total score range is 0 (better outcome) to 100 (worse outcome).
Measured: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Oswestry Disability Index (ODI)
ODI is a 10-item questionnaire developed to evaluate the degree of disability for lower back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability.
Measured: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Adverse Events (AE)
All adverse events complained of by the patient during the period of hospitalization.
Measured: The period of hospitalization is limited to January 2021 to December 2023.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2025
- Study start16 Jul 2024
- Primary completion22 May 2025
- Study completion28 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Musculoskeletal Diseases or ConditionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 1,788 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jaseng Medical Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- In-Hyuk Ha, Ph.D, Study director, Jaseng Medical Foundation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07007299
- Sponsor's protocol ID
- JS-CT-2024-07
- Status last verified
- Feb 2026
- First submitted
- 25 Apr 2025
- Last updated
- 25 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Shin JY, Lee YS, Lee SH, Noh JH, Lee YJ, Ha IH, Lee SW. Real-world evidence on the safety and effectiveness of integrative Korean medicine for older patients post-traffic accident: A retrospective observational study. Medicine (Baltimore). 2025 Nov 28;104(48):e46144. doi: 10.1097/MD.0000000000046144.
PubMed 41327701
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident: Retrospective Chart Review Study
- ClinicalTrials.gov ID
- NCT07007299
- Acronym / sponsor ID
- JS-CT-2024-07
- Conditions
- Musculoskeletal Diseases or Conditions, Traffic Accident, Elderly (People Aged 65 or More)
- Keywords
- pharmacopuncture, herbal medicine, elderly, korean medicine, complementary and alternative medicine, acupuncture
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,788 participants (actual)
- Lead sponsor
- Jaseng Medical FoundationUniversity, hospital or other
- Study start
- 16 Jul 2024 (actual)
- Primary completion
- 22 May 2025 (actual)
- Study completion
- 28 Jul 2025 (actual)
- First posted
- 5 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.
Detailed description
This study was retrospective chart review study and was conducted in 4 branches of Jaseng Korean Medicine Hospital (Gangnam, Bucheon, Daejeon, Haeundae).
Study design
- Observational model
- Other
- Time perspective
- Retrospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- From January 1, 2021 to December 31, 2023, only patients aged 65 years or older who visited the four branches of Jaseng Oriental Hospital (Gangnam, Bucheon, Daejeon, Haeundae) and received inpatient treatment after being injured in a traffic accident and who meet the selection criteria are eligible.
Key inclusion criteria (2 listed)
- Patients aged 65 years or older at the time of first visit
- Patients who visited our hospital due to symptoms caused by a traffic accident and received integrated oriental medicine treatment at least once as an inpatient treatment
Key exclusion criteria (3 listed)
- If only consultation was conducted at the hospital or only Western medicine treatment was conducted
- If only outpatient treatment was received without hospitalization
- If other researcher judges that participation in the study is difficult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Numeric Rating Scale (NRS)
Time frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
NRS uses an 11-point scale to evaluate current main pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.
4 secondary outcomes
euroqol-5 dimension (EQ-5D)
Time frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Neck Disability Index (NDI)
Time frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Oswestry Disability Index (ODI)
Time frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.
Adverse Events (AE)
Time frame: The period of hospitalization is limited to January 2021 to December 2023.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2026.
- Derived from this study: PubMed 41327701Shin JY, Lee YS, Lee SH, Noh JH, Lee YJ, Ha IH, Lee SW. Real-world evidence on the safety and effectiveness of integrative Korean medicine for older patients post-traffic accident: A retrospective observational study. Medicine (Baltimore). 2025 Nov 28;104(48):e46144. doi: 10.1097/MD.0000000000046144.
Related trials for Musculoskeletal Diseases or Conditions
Recruiting
ITPB 1 vs 3 in VATS
Musculoskeletal Diseases or Conditions
Recruiting
Minimum Effective Local Anesthetic Volume for Ultrasound Guided Superior Trunk Block
Musculoskeletal Diseases or Conditions
RecruitingPhase 4
Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block
Musculoskeletal Diseases or Conditions
Recruiting
Sensorimotor Block Dynamics and Hemidiaphragmatic Palsy: Selective Trunk Block vs Supraclavicular Brachial Plexus Block
Musculoskeletal Diseases or Conditions
RecruitingPhase 3
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Obesity, Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
In-Hyuk Ha, Ph.D study director
Jaseng Medical Foundation
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Musculoskeletal Diseases or Conditions and Traffic Accident, run by Jaseng Medical Foundation at 4 sites in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Numeric Rating Scale (NRS) (time frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07007299, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.